Innovative Investment Focus Beyond Celiac's recent investment into RheumaGen highlights their active engagement in funding cutting-edge cell and gene therapies for autoimmune diseases, presenting opportunities to explore partnerships or technology collaborations in advanced therapeutics.

Leadership Accessibility The elevation of Mary Kate Carofano to President signifies a strong leadership team focused on strategic growth and research development, making the organization receptive to innovative solutions that support fundraising, communication, and scientific initiatives.

Research Community Engagement Participation in global events like the International Celiac Disease Symposium demonstrates Beyond Celiac’s commitment to scientific collaboration, offering prospects for companies providing research tools, data analytics, or educational platforms aimed at advancing celiac research.

Growing Market Impact With a revenue range of $10 million to $25 million and recent strategic investments, Beyond Celiac presents a substantial platform for sales of healthcare technology, patient education solutions, or pharmaceutical partnerships targeting celiac disease and related disorders.

Digital and Data Focus Utilizing tools like WordPress, Facebook Pixel, and Piwik PRO, Beyond Celiac emphasizes digital outreach and data-driven engagement, creating opportunities to offer marketing services, analytics solutions, or platform enhancements to further expand their advocacy and research efforts.